KCT0001366已完成未知
A Double-blind, Randomized, Multicenter, Placebo-controlled Exploratory Clinical Trial of the Efficacy and Safety of Igatan F Capsulein gingivitis patients or mild to moderate chronic periodontitis patients
Myungin Pharm0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 79(Year)（—）
- 性别
- All
入选标准
- •1. Male and female of at least 18 years of age but not older than 80 years
- •2. PD(Probing Depth) 4~6mm
- •3. Gingivitis patients or mild to moderate chronic periodontitis patients
排除标准
- •1. Severe chronic periodontitis patients
- •2. History of hypersensitivity to IGATAN F Capsule or any related products
- •3. Any clinical dental treatment(including scaling) in the previous 1 month before day 1 of this study
- •4. Females are pregnant or lactating
- •6. Volunteers who took an Investigational Product in previous 3months before day 1 of this study
研究者
相似试验
未知
3 期
A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Fingolimod 0.5 mg Administered Orally Once Daily Versus Placebo in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)JPRN-jRCT2080221916Mitsubishi Tanabe Pharma Corporation, Novartis Pharma K.K.156
进行中（未招募）
不适用
A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel Group, Dose Ranging Study to Assess the Efficacy, Safety, and Pharmacokinetics of an Oral Thrombopoietin Receptor Agonist SB-497115-GR Administered at 50, 75, and 100 mg to Cancer Patients receiving Multiple Cycles of ChemotherapyTreatment of chemotherapy induced thrombocytopenia with carboplatin and paclitaxel in advanced solid tumors.MedDRA version: 6.1Level: HLTClassification code 10029105EUCTR2004-000368-28-ITGLAXO SMITHKLINE164
进行中（未招募）
不适用
A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)- Epilepsy - Generalized Tonic-Clonic SeizuresMedDRA version: 17.1Level: PTClassification code 10015037Term: EpilepsySystem Organ Class: 10029205 - Nervous system disordersEUCTR2014-004401-32-Outside-EU/EEACB Japan Co. Ltd.361
进行中（未招募）
不适用
A Randomized, Double-blind, Multicenter, Placebo-controlled Study of Adjuvant Lapatinib in Women with Early-Stage ErbB2 Overexpressing Breast Cancer - not availableEUCTR2005-005186-10-GRGlaxoSmithKline A.E.B.E3,000
进行中（未招募）
不适用
A Randomized, Double-blind, Multicenter, Placebo-controlled Study of Adjuvant Lapatinib in Women with Early-Stage ErbB2 Overexpressing Breast CancerEUCTR2005-005186-10-DKGlaxoSmithKline Research & Development Limited3,000